d-IBS
Showing 1 - 25 of 7,004
Irritable Bowel Syndrome With Diarrhea Trial (CIN-103, Placebo)
Not yet recruiting
- Irritable Bowel Syndrome With Diarrhea
- CIN-103
- Placebo
- (no location specified)
Nov 22, 2023
Diarrhea-Predominant Irritable Bowel Syndrome Trial (Changyanning tablet, Changyanning tablet )
Not yet recruiting
- Diarrhea-Predominant Irritable Bowel Syndrome
- Changyanning tablet
- Changyanning tablet placebo
- (no location specified)
Jan 13, 2023
Irritable Bowel Syndrome With Diarrhea, Irritable Bowel Syndrome Trial (Probiotic, Placebo)
Not yet recruiting
- Irritable Bowel Syndrome With Diarrhea
- Irritable Bowel Syndrome
- Probiotic
- Placebo
- (no location specified)
Feb 22, 2023
IBS - Irritable Bowel Syndrome, Diarrhea Trial in Shanghai, Chengdu (QiMeiYan Probiotics, Placebo product)
Not yet recruiting
- IBS - Irritable Bowel Syndrome
- Diarrhea
- QiMeiYan Probiotics
- Placebo product
-
Shanghai, Shanghai, China
- +1 more
Jun 2, 2023
Irritable Bowel Syndrome With Diarrhea Trial in Messina (Verum 408, Placebo 407)
Recruiting
- Irritable Bowel Syndrome With Diarrhea
- Verum 408
- Placebo 407
-
Messina, ItalyGioacchino Calapai
Nov 7, 2023
Irritable Bowel Syndrome of Diarrhea Type (IBS-D) Trial (OPS-2071, )
Not yet recruiting
- Irritable Bowel Syndrome of Diarrhea Type (IBS-D)
- OPS-2071
- placebo
- (no location specified)
Jun 20, 2023
IBS - Irritable Bowel Syndrome Trial in Izmir (Probiotic formulation, Placebo)
Recruiting
- IBS - Irritable Bowel Syndrome
- Probiotic formulation
- Placebo
-
İzmir, TurkeyEge University Faculty of Medicine, Gastroenterology Department
Aug 18, 2022
Vitamin D on Gut Microbiota, Intestinal Barrier in IBS-D
Recruiting
- Diarrhea-predominant Irritable Bowel Syndrome
-
Xi'an, Shaanxi, ChinaThe second affiliated hospital of xi'an jiaotong university
Oct 21, 2022
Irritable Bowel Syndrome With Diarrhea Trial in Mexico City (lactobacillus LB, )
Recruiting
- Irritable Bowel Syndrome With Diarrhea
- lactobacillus LB
- placebo
-
Mexico City, Choose Any State/Province, MexicoHospital General de Mexico
Mar 15, 2022
Irritable Bowel Syndrome Trial in Clermont-Ferrand (Ethosuximide, Placebo)
Active, not recruiting
- Irritable Bowel Syndrome
- Ethosuximide
- Placebo
-
Clermont-Ferrand, FranceCHU Clermont-Ferrand
Jan 5, 2023
Non-erosive Reflux Disease, Diarrhea-Predominant Irritable Bowel Syndrome Trial in Beijing (WPQW granule, WPQW granule simulant)
Recruiting
- Non-erosive Reflux Disease
- Diarrhea-Predominant Irritable Bowel Syndrome
- WPQW granule
- WPQW granule simulant
-
Beijing, Beijing, ChinaXiyuan Hospital of China Academy of Chinese Medical Sciences
May 10, 2022
Early Signs of Parkinsons Disease in IBS
Recruiting
- Parkinson Disease
- Irritable Bowel Syndrome
-
Örebro, SwedenCampus USÖ, Örebro University
Oct 5, 2022
Irritable Bowel Syndrome Trial in Rouen (Colonoscopy with eleven biopsies in the left colon to assess intestinal permeability)
Completed
- Irritable Bowel Syndrome
- Colonoscopy with eleven biopsies in the left colon to assess intestinal permeability
-
Rouen, FranceRouen University Hospital
May 19, 2022
Irritable Bowel Syndrome With Constipation Trial in Dijon (Probiotics mixture)
Recruiting
- Irritable Bowel Syndrome With Constipation
- Probiotics mixture
-
Dijon, Bourgogne, FranceCEN Nutriment
Mar 8, 2022
Irritable Bowel Syndrome Trial in United States (25mg Eluxadoline, 100mg Eluxadoline)
Recruiting
- Irritable Bowel Syndrome
- 25mg Eluxadoline
- 100mg Eluxadoline
-
Corona, California
- +7 more
Nov 11, 2021
IBS - Irritable Bowel Syndrome Trial in Roma (Multistrain probiotic)
Completed
- IBS - Irritable Bowel Syndrome
- Multistrain probiotic
-
Roma, RM, ItalyFondazione Policlinico Gemelli
May 21, 2021
Ischemic Heart Disease, Coronary Heart Disease Trial in Spain
Recruiting
- Ischemic Heart Disease
- Coronary Heart Disease
-
Granada, Andalucia, Spain
- +5 more
Feb 1, 2023
Irritable Bowel Syndrome With Diarrhea Trial in Los Angeles (Rifaximin, N-acetylcysteine, Placebo)
Active, not recruiting
- Irritable Bowel Syndrome With Diarrhea
- Rifaximin
- +2 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Nov 3, 2021
Irritable Bowel Syndrome With Diarrhea Trial in Rochester (Eluxadoline)
Completed
- Irritable Bowel Syndrome With Diarrhea
-
Rochester, MinnesotaMayo Clinic
Apr 28, 2021
Irritable Bowel Syndrome Trial in Ireland, United Kingdom, United States (Blautix, Placebo)
Completed
- Irritable Bowel Syndrome
- Blautix
- Placebo
-
Huntsville, Alabama
- +33 more
Dec 22, 2021
Irritable Bowel Syndrome With Diarrhea (IBS-D) Trial in Vienna (2.0g G-PUR®, oral administration, Placebo, oral administration)
Recruiting
- Irritable Bowel Syndrome With Diarrhea (IBS-D)
- 2.0g G-PUR®, oral administration
- Placebo, oral administration
-
Vienna, AustriaDepartment of Clinical Pharmacology, Medical University of Vienn
Nov 12, 2020
Irritable Bowel Syndrome Trial in United States (Olorinab, Placebo)
Irritable Bowel Syndrome, Vitamin D Deficiency, Abdominal Pain Trial in Boston (Vitamin D, )
Terminated
- Irritable Bowel Syndrome
- +2 more
- Vitamin D
- placebo
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
May 4, 2020